439 related articles for article (PubMed ID: 36058940)
1. Osteoporosis pathogenesis and treatment: existing and emerging avenues.
Liang B; Burley G; Lin S; Shi YC
Cell Mol Biol Lett; 2022 Sep; 27(1):72. PubMed ID: 36058940
[TBL] [Abstract][Full Text] [Related]
2. Capture the fracture – Use of bone turnover markers in clinical practice.
Vuksanović M; Beljić-Živković T
Srp Arh Celok Lek; 2016; 144(7-8):450-5. PubMed ID: 29652458
[TBL] [Abstract][Full Text] [Related]
3. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
[TBL] [Abstract][Full Text] [Related]
4. Muscle-derived extracellular vesicles improve disuse-induced osteoporosis by rebalancing bone formation and bone resorption.
Huang H; Ma S; Xing X; Su X; Xu X; Tang Q; Gao X; Yang J; Li M; Liang C; Wu Y; Liao L; Tian W
Acta Biomater; 2023 Feb; 157():609-624. PubMed ID: 36526242
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Treatments for Osteoporosis-Which Combination of Pills Is the Best among the Bad?
Tonk CH; Shoushrah SH; Babczyk P; El Khaldi-Hansen B; Schulze M; Herten M; Tobiasch E
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163315
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Osteoporosis.
Al Saedi A; Stupka N; Duque G
Handb Exp Pharmacol; 2020; 262():353-367. PubMed ID: 32297003
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis: From Molecular Mechanisms to Therapies.
Tang CH
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979046
[TBL] [Abstract][Full Text] [Related]
8. Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies.
Iolascon G; Resmini G; Tarantino U
Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S19-22. PubMed ID: 24046050
[TBL] [Abstract][Full Text] [Related]
9. Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target.
Kartner N; Manolson MF
Expert Opin Drug Discov; 2014 May; 9(5):505-22. PubMed ID: 24749538
[TBL] [Abstract][Full Text] [Related]
10. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Cellular mechanism and etiology of osteoporosis].
Koga T; Takayanagi H
Clin Calcium; 2015 Sep; 25(9):1293-300. PubMed ID: 26320528
[TBL] [Abstract][Full Text] [Related]
11. The Development of Molecular Biology of Osteoporosis.
Gao Y; Patil S; Jia J
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360948
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of ginsenosides on osteoporosis for novel drug applications.
Liu R; Xu LX; Tong LJ; Wu HY; Guo Q; Sun ZM; Yan H
Eur J Pharmacol; 2024 Jul; 974():176604. PubMed ID: 38649090
[TBL] [Abstract][Full Text] [Related]
13. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
Riggs BL; Parfitt AM
J Bone Miner Res; 2005 Feb; 20(2):177-84. PubMed ID: 15647810
[TBL] [Abstract][Full Text] [Related]
14. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
[TBL] [Abstract][Full Text] [Related]
15. Inadequate response to treatment reveals persistent osteoclast bone resorption in osteoporotic patients.
Léger B; Fardellone P; Cormier C; Ostertag A; Funck-Brentano T; Fabre S; Marty C; Jean-Luc B; Cohen-Solal M
Bone; 2021 Dec; 153():116167. PubMed ID: 34492359
[TBL] [Abstract][Full Text] [Related]
16. The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review.
Xu J; Yu L; Liu F; Wan L; Deng Z
Front Immunol; 2023; 14():1222129. PubMed ID: 37475866
[TBL] [Abstract][Full Text] [Related]
17. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.
Xia WF; Jung JU; Shun C; Xiong S; Xiong L; Shi XM; Mei L; Xiong WC
J Bone Miner Res; 2013 Oct; 28(10):2122-35. PubMed ID: 23649480
[TBL] [Abstract][Full Text] [Related]
18. Aging of the Bone.
Wei Y; Sun Y
Adv Exp Med Biol; 2018; 1086():189-197. PubMed ID: 30232760
[TBL] [Abstract][Full Text] [Related]
19. [Rational bases for the treatment of osteoporosis].
Adami S; Bianchini D; Zanfisi C; Fracassi E; Galvanini G
Ann Ital Med Int; 1995 Oct; 10 Suppl():18S-21S. PubMed ID: 8562260
[TBL] [Abstract][Full Text] [Related]
20. IL-6, IL-1β, and TNF-α only in combination influence the osteoporotic phenotype in Crohn's patients via bone formation and bone resorption.
Blaschke M; Koepp R; Cortis J; Komrakova M; Schieker M; Hempel U; Siggelkow H
Adv Clin Exp Med; 2018 Jan; 27(1):45-56. PubMed ID: 29521042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
